Depression
Drugs Market Size and Growth Rate:
According to the Research Report By Research Cosmos, the global
depression drug market was valued at USD 14.50 billion in 2015 and is
anticipated to generate revenue of USD 16.80 billion by end of 2021, growing at
a CAGR of 2.5% between 2015 and 2021.
Browse details of 165 number of pages
research report developed on Depression
Drugs Market @ https://www.researchcosmos.com/reports/depression-drugs-market/1339532145
Depression
Drugs Market Overview:
Depression drugs market is rising, which is
attributed to rising ubiquity of depression and other mood complications with
the expanding availability of different anti-depressants in the market. Factors
such as growing reliance on medications for controlling the symptoms of
inflation is expected to contribute significantly to the depression drugs
market return in the near future.
In
addition to this, increasing healthcare expenditure, and building insurance
coverage also aids the growth of the market as an increasing number of
relatives of depressive cases are using early measures to halt the
deterioration process. Also, the availability of newer anti-depressants drives
the depression drugs market, providing enormous possibilities to the companies
within this market. Nevertheless, side effects compared with these drugs along
including the availability of other treatment approaches such as psychotherapy
is expected to hinder the revenue increase of these drugs over the forecast
period.
Based on the distribution channel, the global
depression drugs market has been divided into online pharmacies, hospital
pharmacies, and local pharmacies. The retail pharmacies segment held an
important market share in 2017 and is expected to dominate the market during
the projection period. This is attributed to the rise in the prevalence of
major depressive disorders over the world and an increase in preference of
depressed patients to obtain from direct pharmacies. Nevertheless, the hospital
pharmacies and retail pharmacies segments are predicted to lose market share,
owing to exclusivity expiry of these remedies.
Ask Free Sample of the report @ https://www.researchcosmos.com/request/depression-drugs-market/1339532145
Depression
Drugs Market Geographical Insights:
North America developed the leading share of the
global depression drugs market in 2018. North America is the home company of
many important players of the global market and is expected responsible for the
dominance of market share of the region. Europe estimated for the second
principal share of the business, which can be ascribed to the development in
research and development activities in the area. The depression drugs business
in the Middle East & Africa is anticipated to grow at a significant rate
during the projected period. Development in government initiatives in the
health care division in the developing nations of the region is projected to
fuel the increase of the market in the region.
The Depression Drugs market is anticipated to
grow with the fastest CAGR over the forecast period due to the increasing
number of pipeline antidepressants. Growing competition among major companies
in the market to get new formulation drugs which cures more than one symptom,
driving the market.The retail pharmacies segment held an important market share
in 2017 and is expected to dominate the market during the projected period.North
America developed the leading share of the global depression drugs market in
2018.
Key
Players of the Depression Drugs Market:
- Novartis International AG
- Janssen Pharmaceuticals, Inc.
- Lupin Pharmaceuticals, Inc.
- Abbott Laboratories
- Allergan, Plc
- MSI Methylation Sciences Inc.
- Luye Pharma Group Ltd.
- H. Lundbeck A/S
For
any queries, inquire more @ https://www.researchcosmos.com/inquire/depression-drugs-market/1339532145
About
Us:
Research Cosmos
is a provider of standard and customized market research, business intelligence
and consulting services across more than 100 domains in different industries of
the world. We host the trending market reports of the world’s top-notch publishing
companies, offering services to a wide range of customers from students to
fortune 500 companies and discloses the hidden opportunities in every leading
industry of the world.
Contact:
Kevin Stewart
Global Sales Manager
Research Cosmos
No comments:
Post a Comment